Status:
TERMINATED
Glucose and Non-Invasive Brain Stimulation
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Glucose Metabolism Disorders
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Purpose: In this study, the investigators will delineate how brain network dynamics are modulated by experimentally induced elevated blood glucose levels and examine how glucose levels gate neuronal e...
Detailed Description
This study will be a placebo-controlled study that investigates brain function with both electroencephalography (EEG) and TMS. On each study visit, a drink (either glucose drink or water) is administe...
Eligibility Criteria
Inclusion
- Right-handed
- BMI \<30
- Free of major neurological conditions and diabetes
Exclusion
- Diabetes
- Adverse reaction to finger prick blood draw
- Known neurological or psychiatric illness
- Prior brain surgery
- Any brain devices/implants, including cochlear implants and aneurysm clips
- Cardiac pacemaker
- Any other implanted electronic device
- History of current traumatic brain injury
- Anything that, in the opinion of the investigator, would place the participant at increased risk or preclude the participant's full compliance with or completion of the study
Key Trial Info
Start Date :
September 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2020
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT04031404
Start Date
September 11 2019
End Date
August 31 2020
Last Update
September 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UNC Medical School Wing C
Chapel Hill, North Carolina, United States, 27514